Selected Grants
1/3 CTSA UM1 at Duke University
ResearchFaculty Member · Awarded by National Institutes of Health · 2025 - 20321/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2030Evaluation of inclisiran versus placebo for the prevention of major adverse cardiovascular and limb events in patients undergoing percutaneous coronary intervention or peripheral endovascular intervention (VICTORIAN-INTERVENTION)
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2025 - 2029V-Intervention
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2025 - 2029Phase 4 Coordinating Center Services PFA: Engagement and Public Awareness Services
ResearchPrincipal Investigator · Awarded by Vanderbilt University · 2025 - 2028Protect IV
Clinical TrialCo-Principal Investigator · Awarded by Abiomed, Inc. · 2024 - 2028Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028A TriaL ComparIng the EffectiVEness and ToleraBility of MEdicaTions in Older Adults with STablE Angina and Multiple ChRonic Conditions: The LIVE BETTER Trial
ResearchPrincipal Investigator · Awarded by Yale University · 2022 - 2027PREvention of CardIovascular and DiabEtic kidNey disease in Type 2 Diabetes
Clinical TrialPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2022 - 2027Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Clinical TrialCo-Principal Investigator · Awarded by Procyrion, Inc. · 2023 - 2026COVID-19 Electronic Health Data Initiative
ResearchPrincipal Investigator · Awarded by The Task Force for Global Health · 2024 - 2026OCEANIC-AFINA
Clinical TrialPrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2023 - 2026RECOVER - Subaward from CHOP
ResearchPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2021 - 2026Bayer OCEANIC CEC Stroke SOW
Clinical TrialPrincipal Investigator · Awarded by Bayer HealthCare Pharmaceuticals, Inc · 2024 - 2026VITALITY
Clinical TrialPrincipal Investigator · Awarded by Bayer HealthCare AG · 2018 - 2025Program to Reduce dispArities In the ScrEening for Peripheral Artery Disease among black patients (PRAISE-PAD)
ResearchPrincipal Investigator · Awarded by American College of Cardiology Foundation · 2024 - 2025Postdoctoral Training in Cardiovascular Clinical Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2025PCORnet CC - Scope 6 - Playbook
ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2024 - 2025Implementation of a Medication Adherence Instrument among Patients with Symptomatic Peripheral Artery Disease after Peripheral Vascular Intervention
ResearchCo-Mentor · Awarded by National Institutes of Health · 2023 - 2025PCORnet® Infrastructure Capacity Building: Recommendations and Roadmap to Enhance PCORnet Informatics and Capacity for Patient-Centered CER
ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2023 - 2024Study to Test Risk factor Improvement through Dedicated Education, Engagement, and assessment of patient symptoms in the Cardiac Cath Lab (STRIDE-Cath Lab)
Clinical TrialPrincipal Investigator · Awarded by Mytonomy Inc. · 2019 - 2024Empowering the Participant Voice: Collaborative Infrastructure and Validated Tools for Collecting Participant Feedback to Improve the Clinical Research Enterprise
ResearchCo-Principal Investigator · Awarded by Rockefeller University · 2020 - 2024COVID-19 Electronic Health Data Initiative
ResearchPrincipal Investigator · Awarded by The Task Force for Global Health · 2023 - 2024The Impact of Care Fragmentation and Healthcare Disparities in Peripheral Artery Disease
FellowshipPrincipal Investigator · Awarded by American College of Cardiology · 2023 - 2024Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period
ResearchCo Investigator · Awarded by Food and Drug Administration · 2022 - 2024Medications and Weight Gain Across the Lifecourse in PCORnet
ResearchPrincipal Investigator · Awarded by Harvard Medical School · 2020 - 2024EMPACT-MI: A streamlined, multicenter, randomized, parallel group, double-blind placebo-controlled superiority trial to evaluate the effect of EMPAgliflozin on hospitalization for heart failure and mortality in patients with aCuTe Myocardial Infarct
Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Corporation · 2021 - 2024PAD/CAD Design Studio
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2023 - 2023ECLIPSE
Clinical TrialPrincipal Investigator · Awarded by Cardiovascular Systems Inc. · 2017 - 2023Implementation of a Medication Adherence Instrument Among Patients with Symptomatic Peripheral Artery Disease after PVI
ResearchMentor · Awarded by American Heart Association · 2022 - 2023ADAPTABLE Supplement
Clinical TrialInvestigator · Awarded by Patient-Centered Outcomes Research Institute · 2015 - 2023ADAPTABLE Manuscripts
Clinical TrialPrincipal Investigator · Awarded by Bayer HealthCare, LLC · 2021 - 2022Sentinel Initiative: CDRN Work Order 1:Sentinel Operations Center "RWE: Establish Routine Querying Capability with a Network of EHR Database"
ResearchPrincipal Investigator · Awarded by Harvard Pilgrim Health Care, Inc. · 2021 - 2022Benefit Risk Tradeoffs Associated with PRO for PAD
ResearchCo Investigator · Awarded by Food and Drug Administration · 2020 - 2022COVID-19 Electronic Health Data Initiative-Amendment 1
ResearchPrincipal Investigator · Awarded by The Task Force for Global Health · 2020 - 2022Addressing variability in peripheral arterial disease outcomes using machine learning techniques
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022Enhanced X-ray Angiography Analysis and Interpretation Using Deep Learning
ResearchInvestigator · Awarded by Vigilant Medical · 2019 - 2022PACE-CLI (PLX-CLI-03)
Clinical TrialPrincipal Investigator · Awarded by Pluristem Therapeutics Inc. · 2018 - 2021Advancement of PCORnet Infrastructure: Clinical Research Network Project - COVID supplement
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2020 - 2021Subaward ECU/Mishriky Trial Data Extraction
ResearchPrincipal Investigator · Awarded by East Carolina University · 2020 - 2021DEFINE-PCI
Clinical TrialPrincipal Investigator · Awarded by Volcano Corporation · 2017 - 2021VOYAGER
Clinical TrialPrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2015 - 2021ADAPTABLE
Clinical TrialPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2016 - 2021A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM INVESTIGATIONAL STUDY IN HIGH OR EXTREME RISK PATIENTS WITH SYMPTOMATIC, SEVERE NATIVE AORTIC STENOSIS
Clinical TrialPrincipal Investigator · Awarded by Abbott Cardiovascular Systems, Inc. · 2019 - 2021CDRN Data Extraction for UNCA-UNC Covid project
ResearchPrincipal Investigator · Awarded by University of North Carolina - Asheville · 2020 - 2020Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2017 - 2020MSCDRN application
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2018 - 2020Master Plan for Integration of Innovation Technologies and IC Collaboration Activities
ResearchCo Investigator · Awarded by Harvard Pilgrim Health Care, Inc. · 2019 - 2020Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Clinical TrialInvestigator · Awarded by Patient-Centered Outcomes Research Institute · 2015 - 2020The Duke Renal Impairment Program (DRIP) Initiative
ResearchCo Investigator · Awarded by American College of Cardiology Foundation · 2019 - 2020Splanchnic Nerve Block for Therapy of Acute Heart Failure (Splanchnic HF)
Clinical TrialCo Investigator · Awarded by American Heart Association · 2017 - 2019National Patient-Centered Clinical Research Network (PCORnet): Clinical Data Research Networks(CDRNs) Phase II
ResearchPrincipal Investigator · Awarded by South Carolina Research Foundation · 2015 - 2019Panachen 17582
Clinical TrialPrincipal Investigator · Awarded by Bayer HealthCare AG · 2017 - 2019Pantheon 15128
Clinical TrialPrincipal Investigator · Awarded by Bayer Pharmaceuticals · 2017 - 2018CSI Educational Program Agreement VIII
ConferencePrincipal Investigator · Awarded by Cardiovascular Systems Inc. · 2017 - 2017Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01)
ResearchCo Investigator · Awarded by Food and Drug Administration · 2013 - 2017ENDOMAX CEC and DSMB
Clinical TrialPrincipal Investigator · Awarded by The Medicines Company · 2013 - 2017Variability, Medical Therapy, and Outcomes in Patients with Peripheral Artery Disease Who Undergo Lower Extremity Endovascular Revascularization Procedures
ResearchPrincipal Investigator · Awarded by American Heart Association · 2014 - 2015TO # 1 - Coordinating Center for Cardiovascular Disease - OPTION YEAR 2
ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2011 - 2013PTEN Gene Therapy for Vein Graft Disease
ResearchFellow · Awarded by National Institutes of Health · 2009 - 2012TO # 1 - Coordinating Center for Cardiovascular Disease
ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2010 - 2011External Relationships
- Amplitude Vascular Systems
- Bayer
- Novartis pharmaceuticals
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.